20250130_SMLE_Ringkasan Risalah//Risalah RUPS_31848288_lamp1.pdf

E.   Perseroan telah memberikan kesempatan kepada pemegang saham
     dan kuasa pemegang saham untuk mengajukan pertanyaan dan/atau
     memberikan pendapat sebelum dilaksanakannya pengambilan
     keputusan untuk setiap mata acara Rapat.

F.   Dalam Rapat, terdapat pemegang saham yang mengajukan pertanyaan
     dan/atau memberikan pendapat terkait mata acara Rapat, yaitu Bapak
     SAMIN, selaku pemilik/pemegang 16.000 saham dalam Perseroan.

G.   Mekanisme pengambilan keputusan Rapat:
     1.  Mekanisme pengambilan keputusan Rapat dilakukan secara
         musyawarah untuk mufakat. Namun apabila musyawarah untuk
         mufakat tidak tercapai, maka pengambilan keputusan dalam
         Rapat dilakukan dengan cara pemungutan suara (voting) secara
         terbuka.
     2.  Pemegang Saham diperkenankan memberikan suara melalui
         Electronic General Meeting System KSEI (eASY.KSEI) yang
         disediakan oleh PT KUSTODIAN SENTRAL EFEK INDONESIA
         (“KSEI”).
     3.  Berdasarkan Pasal 47 POJK 15/2020, pemegang saham dengan
         hak suara yang sah dan telah hadir, baik secara fisik maupun
         secara elektronik dalam Rapat, namun tidak menggunakan hak
         suaranya atau abstain, dianggap sah menghadiri Rapat dan
         memberikan suara yang sama dengan suara mayoritas pemegang
         saham yang memberikan suara dengan menambahkan suara
         dimaksud pada suara mayoritas pemegang saham yang
         mengeluarkan suara.

H.   Hasil pemungutan suara:
     Berhubung tidak ada pemegang saham yang mengajukan keberatan,
     maka Rapat dengan suara bulat memutuskan untuk menyetujui usulan
     keputusan mata acara Rapat yang telah disampaikan.

I.   Hasil keputusan Rapat:
     1.    Menyetujui perubahan ketentuan Pasal 3 ayat (1) dan (2)
           Anggaran Dasar Perseroan mengenai Maksud dan Tujuan serta
           Kegiatan Usaha Perseroan sehubungan dengan rencana
           menambah kegiatan usaha penunjang Perseroan, yaitu di bidang
           Perdagangan Besar Obat Farmasi untuk Manusia (KBLI 46441)
           dan Perdagangan Besar Bahan Farmasi untuk Manusia dan
           Hewan (KBLI 46447).




                                   2

2.   Memberikan kewenangan dan kuasa kepada Direksi Perseroan
     untuk menyesuaikan Maksud dan Tujuan serta Kegiatan Usaha
     Perseroan sehubungan dengan penambahan kegiatan usaha
     penunjang Perseroan, yaitu di bidang Perdagangan Besar Obat
     Farmasi untuk Manusia (KBLI 46441) dan Perdagangan Besar
     Bahan Farmasi untuk Manusia dan Hewan (KBLI 46447).
3.   Memberikan kuasa kepada Direksi Perseroan untuk menyatakan
     hasil keputusan mata acara Rapat ini kedalam akta Notaris
     tersendiri, termasuk memohon persetujuan perubahan Anggaran
     Dasar Perseroan tersebut kepada instansi yang berwenang, antara
     lain pada Kementerian Hukum Republik Indonesia, membuat
     perubahan dan/atau tambahan dalam bentuk apapun juga yang
     diperlukan untuk diperolehnya persetujuan perubahan Anggaran
     Dasar tersebut, termasuk merubah izin usaha Perseroan,
     mengajukan, menandatangani semua permohonan dan dokumen
     lainnya, memilih tempat kedudukan dan melaksanakan segala
     tindakan yang diperlukan dalam rangka perubahan dan
     penambahan kegiatan usaha Perseroan tersebut, tidak ada yang
     dikecualikan.

                      Jakarta, 30 Januari 2025
               PT SINERGI MULTI LESTARINDO Tbk
                        Direksi Perseroan




                               3

             ANNOUNCEMENT OF SUMMARY OF MINUTES OF
         EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
                 PT SINERGI MULTI LESTARINDO Tbk
                          (“COMPANY”)



In order to fulfill the provisions of Article 49 paragraph (1) and Article 51
paragraph (1) of the Financial Services Authority Regulation No.
15/POJK.04/2020 concerning the Plan and the Implementation of the General
Meeting of Shareholders of Public Company ("POJK 15/2020"), the Board of
Directors of the Company hereby announce the Summary of Minutes of the
Company's Extraordinary General Meeting of Shareholders ("Meeting") as
follows:

A.   The Meeting of the Company has been held on:
     Day/Date      : Friday/ January 24th, 2025;
     Time          : 09.27’ BBWI - 10.11’ BBWI;
     Place         : Plaza Mutiara 8th Floor, Jalan Lingkar Mega Kuningan,
                     Kav. E 1.2 Kuningan, South Jakarta 12950.

B.   The Agenda of the Meeting are as follows:
     Amendment to Article 3 of the Articles of Association concerning the
     Purpose and Objectives and Business Activities, in order to add to the
     Company's business fields.

C.   The Board of Directors and Board of Commissioners of the Company
     who attended the Meeting were as follows:

     BOARD OF DIRECTORS:
     - President Director                    : Mr. SIU MIN;
     - Sales & Marketing Director            : Mrs. YULIA ROSALINE;
     - Finance & Operations Director         : Mrs. TANTI ROYANI;
     - Product Development Director          : Mrs. DESSY SARENDIANI.

     BOARD OF COMMISSIONERS:
     - President Commissioner                : Mr. GUNAWAN;
     - Independent Commissioner              : Mr. DR. BASA SIDABUTAR,
                                               S.H., M.H.

D.   Based on the attendance list of the shareholders of the Meeting, the
     recorded number of shares present or represented in the Meeting is


                                     4

     1.862.631.201 shares, which constitute of 80,0049% from the total
     amount of shares that have been issued by the Company, which have
     valid voting rights as required by the Company's articles of association
     and POJK 15/2020.

E.   The Company has provided opportunities for the shareholders and the
     proxy of shareholders to raised questions and/or provide opinions prior
     to the adoption of resolution for each agenda item of the Meeting.

F.   During the Meeting, there was shareholder who asked question and/or
     provided opinion regarding the agenda of the Meeting, namely
     Mr. SAMIN, as the owner/holder of 16.000 shares in the Company.

G.   The mechanism of adopting resolution of Meeting:
     1.  The mechanism of adopting resolution of Meeting was conducted
         in amicable manner. If no amicable resolution is reached, voting
         system is implemented in the Meeting through open voting system.
     2.  Shareholders were allowed to vote through Electronic General
         Meeting System KSEI (eASY.KSEI) provided by PT KUSTODIAN
         SENTRAL EFEK INDONESIA (“KSEI”).
     3.  Based on Article 47 of POJK 15/2020, shareholders with valid
         voting rights and have been present, both physically and
         electronically at the Meeting, but have not exercised their voting
         rights or abstained, are considered valid to attend the Meeting and
         cast the same vote as the majority of the voting shareholders by
         adding the said vote to the votes of the majority of the voting
         shareholders.

H.   Voting results:
     Since no shareholders raised objections, the Meeting unanimously
     resolved to approve the proposed resolutions on the agenda of the
     Meeting that had been submitted.

I.   Resolutions of the Meeting:
     1.  Approve the changes to the provisions of Article 3 paragraph (1)
         and (2) of the Company's Articles of Association regarding the
         Purpose and Objectives and Business Activities of the Company in
         connection with the plan to add supporting business activities of the
         Company, namely in the field of Wholesale of Pharmaceutical
         Drugs for Humans (KBLI 46441) and Wholesale of Pharmaceutical
         Materials for Humans and Animals (KBLI 46447).
     2.  Grant authority and power to the Company's Board of Directors to
         adjust the Purpose and Objectives and Business Activities of the


                                      5

     Company in connection with the addition of supporting business
     activities of the Company, namely in the field of Wholesale of
     Pharmaceutical Drugs for Humans (KBLI 46441) and Wholesale of
     Pharmaceutical Materials for Humans and Animals (KBLI 46447).
3.   Grant power to the Board of Directors of the Company to state the
     results of the resolutions of the agenda of the Meeting in a
     separate Notarial deed, including requesting approval for changes
     to the Company's Articles of Association to the authorized agency,
     including the Ministry of Law of the Republic of Indonesia, making
     changes and/or additions in any form whatsoever that are
     necessary to obtain approval for changes to the Articles of
     Association, including changing the Company's business license,
     submitting, signing all applications and other documents, choosing
     a domicile and carrying out all actions necessary for the purpose of
     changes and additions to the Company's business activities, none
     of which are excluded.

                  Jakarta, January 30th, 2025
             PT SINERGI MULTI LESTARINDO Tbk
               Board of Directors of the Company




                                 6